Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Free cash flow yield

Free cash flow yield at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
7.8%—
TFX
TeleflexTFX
2.7%-0.5pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
4.6%+2.4pp
IAR
Integra LifeSciencesIART
2.6%-2.1pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.4%+2.5pp
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
13.4%-2.3pp

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

free cash flow/market cap=6.6%

Based on trailing twelve months.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's free cash flow yield?
Utah Medical Products (UTMD) reported free cash flow yield of 6.6% in Q1 2026.
How has Utah Medical Products's free cash flow yield changed year-over-year?
Utah Medical Products's free cash flow yield decreased by 11.0% year-over-year, from 7.4% to 6.6%.
What is the long-term trend for Utah Medical Products's free cash flow yield?
Over 5 years (2020 to 2025), Utah Medical Products's free cash flow yield has grown at a 5.0% compound annual growth rate (CAGR), from 6.3% to 8%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.